Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
Clinical trial NCT02251184 · COMPLETED
Trial details
- NCT number
- NCT02251184
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2000-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.